The process involves:
● Creating a recombinant spike protein in insect cells using a baculovirus system.
● Arranging these proteins into nanoparticles to enhance the immune response.
● Mixing the nanoparticles with a plant-derived adjuvant (Matrix-M) to further boost immunity.
The vaccine uses nanoparticles to present the antigen. NovaVax is classified as a protein subunit or recombinant nanoparticle vaccine, not an mRNA vaccine.
I find it absolutely hilarious when folks like you make claims with absolutely zero credentials references sources links nothing. To say that nanotech is not validated nor receives toxicity testing is PREPOSTEROUS. Holy fucking shit, Evans ... really? 😆 🤣 😂
Novavax’s COVID-19 vaccine (Nuvaxovid) underwent full validation and toxicity testing. Its approval by regulatory agencies like the FDA was based on large Phase 3 clinical trials showing it was safe and effective. The vaccine’s immunogenicity and safety were rigorously tested, including validated laboratory assays to measure immune response. Ongoing postmarketing studies and additional trials continue to monitor long-term safety and rare side effects as required by regulators.
https://ir.novavax.com/press-releases/2025-05-19-U-S-FDA-Approves-BLA-for-Novavaxs-COVID-19-Vaccine
https://pmc.ncbi.nlm.nih.gov/articles/PMC11205394/
https://www.contagionlive.com/view/fda-requests-additional-trial-novavax-nvx-cov2601-vaccine-prior-approval
.
No comments:
Post a Comment